Your browser doesn't support javascript.
Research progress on action mechanism and preparation of monoclonal antibodies against 2019-nCoV.
Chinese Journal of Clinical Infectious Diseases ; 14(2):91-96, 2021.
Artículo en Chino | EMBASE | ID: covidwho-2287852
ABSTRACT
During the treatment of critically ill COVID-19 patients it has been revealed that the neutralizing monoclonal antibodies against 2019-nCoV have the advantages of high specificity, high purity, and can be prepared in a large scale, which are expected to be a effective preparation for clinical use. This article introduces the way of 2019-nCoV invasion into the host cells, the major variants of novel coronavirus, and the mechanism of action of anti-2019-nCoV monoclonal antibodies, as well as the progress of research and development of their preparation in major pharmaceutical companies, to provide reference for scientific research and clinical application.Copyright © Chinese Journal of Clinical Infectious Diseases.All rights reserved.
Palabras clave

Texto completo: Disponible Colección: Bases de datos de organismos internacionales Base de datos: EMBASE Idioma: Chino Revista: Chinese Journal of Clinical Infectious Diseases Año: 2021 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos de organismos internacionales Base de datos: EMBASE Idioma: Chino Revista: Chinese Journal of Clinical Infectious Diseases Año: 2021 Tipo del documento: Artículo